Phase II Report | 合法醫療器材資訊網

由 JC Yam 著作 · 2020 · 被引用 52 次 — ... among the studied atropine concentrations in slowing myopia progression. ... of the Low-Concentration Atropine for Myopia Progression (LAMP) Study: ... Read More

由 JC Yam 著作 · 2019 · 被引用 213 次 — Purpose: Low-concentration atropine is an emerging therapy for myopia progression, but its efficacy and optimal concentration remain uncertain. Our study aimed ... Read More

由 JC Yam 著作 · 2020 · 被引用 53 次 — Myopia Progression (LAMP) Study. Phase 2 Report. Jason C. Yam, FCOphthHK, FRCS (Edin),1,2,3 Fen Fen Li, MMed,1 Xiujuan Zhang, PhD,1 Shu Min ... Read More

由 JC Yam 著作 · 2020 · 被引用 52 次 — Randomized, double-masked trial extended from the Low-Concentration Atropine for Myopia Progression (LAMP) Study. Read More

2020年1月2日 — This report of the phase II results from the LAMP study indicates that 0.05% atropine (vs 0.01% and 0.025%) was superior at myopia control ... Read More

Low-Concentration Atropine for Myopia Progression (LAMP) Study ... Purpose Low-concentration atropine is an emerging therapy for myopia progression, but its ... Read More